Isolation of vancomycin resistant enterococcus faecium with genotype vanb at the Hospital Clinico regional de concepción;Aislamiento de Enterococcus faecium resistente a vancomicina con genotipo vanB en el Hospital Clínico Regional de Concepción

Revista Chilena de Infectologia

Volumn 19, Issue 1, 2002, Pages 32-36

  Sergio Mella, M ^a   B Q Marcela Sepueveda A ^a   Pamela Acosta, V ^a   B Q Helia Bello, T ^a   B Q Mariana Dominguez, Y ^a   Gerardo Gonzalez R ^a   Q F Raue Zemelman Z ^b   Omar Cofre C ^c  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSIDAD SAN SEBASTIÁN   (Chile)

^c Hospital Regional de Concepcion Dr Guillermo Grant Benavente   (Chile)

Author keywords

Enterococcus faecium; Vancomycin resistance

Indexed keywords

EID: 52649178972     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. MC GOWAN J E Jr. The impact of changing pathogens of serious infections in hospitalized patients. Clin Infect Dis 2000; 31 (Suppl 4): S124-S130.
2. MOELLERING Jr. R C. Introduction: problems with antimicrobial resistance in Gram positive cocci. Clin Infect Dis 1998; 26: 1177-8.
3. FRIDKIN S K. Vancomycin-intermediate and resistant Staphylococcus aureus: What the infectious disease specialist needs to know. Clin Infect Dis 2001; 32: 108-15.
4. IMP,. Antimicrob Agents Chemother 1998; 42:2006-11.
5. MAROVAC J, CAMPOS M I. Enterococcusfaecium resistente a vancomicina. Rev Méd Chile 2000; 128: 685-6.
6. WEBB M, RILEY E W, ROBERTS R B. Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization. Clin Infect Dis 2001; 33: 445-52.
7. BARTON A L, DOERN G V. Selective media for detecting gastrointestinal carriage of vancomycinresistant enterococci. Diagn Microbiol Infect Dis 1995; 23: 119-22.
8. th Edition Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH., eds. ASM Press, Washington DC, 1999; 297-305.
9. CARVALHO M, TEXEIRA L. FACKLAM R. Use of test for acidification of methyl-α-Dglucopyranoside and susceptibility to efrotomycin for differentiation of strains of Enterococcus and some related genera. J Clin Microbiol 1998; 36: 1584-7.
10. th information supplement. NCCLSdocument No. M100-S9. Vol 19. Wayne, PA: NCCLS, 1999.
11. 11.- DUTKA-MALEN S, EVERS S, COURVALIN P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33: 24-7.
12. 12.- DUTKA-MALEN S, EVERS S, COURVALIN P. Detection of glycopeptide resistance genotypes and identification to the species level of clinicallyrelevant enterococci by PCR. J Clin Microbiol 1995; 33(5): 1434.
13. 13.- RIDLEY A N. Genomic fingerprinting by application of rep-PCR. En: Woodford N, Johnson AP. Eds. Methods in Molecular Medicine, Vol 15: Molecular bacteriology: protocols and clinical applications. Totowa, NJ: Humana Press Inc., 1998; 103-15.
14. 14.- BOYCE J M. Vancomycin-resistant Enterococcus. Detection, epidemiology, and control measures. Infect Dis Clin North Am. 1997; 11: 367-84.